Screening method, process for purifying of non-diffusible A-beta oligomers, selective antibodies against said nondiffusible A-beta oligomers and a process for manufacturing of said antibodies

Details for Australian Patent Application No. 2006222193 (hide)

Owner Abbott GmbH & Co. KG

Inventors Ebert, Ulrich; Keller, Patrick; Barghorn, Stefan; Striebinger, Andreas; Hillen, Heinz

Agent Spruson & Ferguson

Pub. Number AU-B-2006222193

PCT Pub. Number WO2006/094724

Priority 60/664,477 23.03.05 US; 60/740,866 30.11.05 US; 05004858.6 05.03.05 EP; 05006568.9 24.03.05 EP

Filing date 3 March 2006

Wipo publication date 14 September 2006

Acceptance publication date 17 November 2011

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

20 September 2007 PCT application entered the National Phase

  PCT publication WO2006/094724 Priority application(s): WO2006/094724

17 November 2011 Application Accepted

  Published as AU-B-2006222193

15 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006222204-Use of MGC4504

2006222191-Cylindrical electrode